TULP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.5355000038706E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.17439999999902E-05 |
Normal-vs-Stage2 |
3.73120000007887E-07 |
Normal-vs-Stage3 |
2.74140043998727E-10 |
Normal-vs-Stage4 |
7.55109974548418E-10 |
Stage1-vs-Stage2 |
4.085600E-02 |
Stage1-vs-Stage3 |
6.564800E-03 |
Stage1-vs-Stage4 |
6.842700E-03 |
Stage2-vs-Stage3 |
8.285000E-01 |
Stage2-vs-Stage4 |
8.551600E-01 |
Stage3-vs-Stage4 |
6.165000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.39969990731981E-10 |
Normal-vs-AfricanAmerican |
3.182900E-04 |
Normal-vs-Asian |
6.186200E-01 |
Caucasian-vs-AfricanAmerican |
6.572600E-01 |
Caucasian-vs-Asian |
9.016000E-03 |
AfricanAmerican-vs-Asian |
5.273800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.22409999914197E-08 |
Normal-vs-Female |
4.57050000068904E-08 |
Male-vs-Female |
5.555000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.257100E-03 |
Normal-vs-Age(41-60Yrs) |
4.49550000003462E-06 |
Normal-vs-Age(61-80Yrs) |
1.21739951453037E-10 |
Normal-vs-Age(81-100Yrs) |
2.04829999961298E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.754200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.108000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.264200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.384100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.054200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.432800E-01 |
Normal-vs-Grade 2 |
2.65970000001836E-06 |
Normal-vs-Grade 3 |
2.09580020005262E-10 |
Normal-vs-Grade 4 |
5.63460389457759E-11 |
Grade 1-vs-Grade 2 |
2.547600E-01 |
Grade 1-vs-Grade 3 |
3.112400E-02 |
Grade 1-vs-Grade 4 |
5.524500E-03 |
Grade 2-vs-Grade 3 |
1.755630E-02 |
Grade 2-vs-Grade 4 |
2.161400E-03 |
Grade 3-vs-Grade 4 |
3.014800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.2616999999987E-05 |
Normal-vs-ccB subtype |
7.74160002769975E-09 |
ccA subtype-vs-ccB subtype |
1.655680E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.7700000050408E-08 |
Normal-vs-N1 |
6.10899999999859E-05 |
N0-vs-N1 |
2.354200E-01 |
|
|